Watch the replay of this GCV Institute ‘Meet the Experts’ event on June 29, spotlighting Dave Stevenson, Managing Director and Strategic COO at Merck Global Health Innovation Fund and featured Global Corporate Venturing Institute mentor and expert. This was the second of the Institute’s quarterly informational and networking events, previewing curriculum content and giving the corporate venture community an opportunity to connect.
Dave discusses the evolution of Merck GHI’s successful approach to building a high performance strategic CVC that delivers top financial results. Merck GHI has had over $6B in exits (including unicorns Livongo and Preventice) over the last 18 months and has become one of the most respected investors in digital health.
